[1]KIM D H, PARK J I, LEE J P, et al.The effects of vascular access types on the survival and quality of life and depression in the incident hemodialysis patients[J].Renal Failure, 2020, 42(1):30-39
[2]LOK C E, HUBER T S, LEE T, et al.KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update[J].American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation, 2020, 75(4 Suppl 2):S1-S164
[3]王铮, 李香.慢性应激在血管内膜增生中的作用及分子机制的研究进展[J].中国临床新医学, 2022, 15(7):658-661
[4]YANG M, CHEN Q, MEI L, et al.Neutrophil elastase promotes neointimal hyperplasia by targeting toll-like receptor 4 (TLR4)-NF-κB signalling[J].British Journal of Pharmacology, 2021, 178(20):4048-4068
[5]DU J, LIANG L, LIU S, et al.Neointimal hyperplasia in the inferior vena cava of adenine-induced chronic kidney disease rats with aortocaval fistulas[J].Clinical and Experimental Nephrology, 2020, 24(11):1007-1014
[6]HSIN K Y, GHOSH S, KITANO H.Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology[J].PloS One, 2013, 8(12):e83922-e83930
[7]GOODSELL D S, ZARDECKI C, DI COSTANZO L, et al.RCSB Protein Data Bank: Enabling biomedical research and drug discovery[J].Protein Science: A Publication of the Protein Society, 2020, 29(1):52-65
[8]YOSHIZUMI M, ABE J I, TSUCHIYA K, et al.Stress and vascular responses: atheroprotective effect of laminar fluid shear stress in endothelial cells: possible role of mitogen-activated protein kinases[J].Journal of Pharmacological Sciences, 2003, 91(3):172-176
[9]LEE T, ROY-CHAUDHURY P.Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis[J].Advances in Chronic Kidney Disease, 2009, 16(5):329-338
[10]董建华, 葛永纯.自体动静脉内瘘功能障碍的机制[J].肾脏病与透析肾移植杂志, 2019, 28(4):379-384
[11]LI Y, WANG Q, XU Q, et al.Valsartan decreases neointimal hyperplasia in balloon-injured rat aortic arteries by upregulating HO-1 and inhibiting angiotensin II type 1 receptor[J].Life Sciences, 2014, 110(2):70-76
[12]XU C, ZHANG N, YUAN H, et al.Sacubitrilvalsartan inhibits the proliferation of vascular smooth muscle cells through notch signaling and ERK12 pathway[J].BMC cardiovascular disorders, 2024, 24(1):106-115
[13]KUSAKA H, SUETA D, KOIBUCHI N, et al.LCZ696,Angiotensin II Receptor-Neprilysin Inhibitor,Ameliorates High-Salt-Induced Hypertension and Cardiovascular Injury More Than Valsartan Alone[J].American Journal of Hypertension, 2015, 28(12):1409-1417
[14]KORSHUNOV V A, QUINN B, FAIYAZ A, et al.Strain-selective efficacy of sacubitrilvalsartan on carotid fibrosis in response to injury in two inbred mouse strains[J].British Journal of Pharmacology, 2019, 176(15):2795-2807
[15]CHAN A K, KALMES A, HAWKINS S, et al.Blockade of the epidermal growth factor receptor decreases intimal hyperplasia in balloon-injured rat carotid artery[J].Journal of Vascular Surgery, 2003, 37(3):644-649
[16]PASTORE C J, ISNER J M, BACHA P A, et al.Epidermal growth factor receptor-targeted cytotoxin inhibits neointimal hyperplasia in vivoResults of local versus systemic administration[J].Circulation Research, 1995, 77(3):519-529
[17]PICKERING J G, BACHA P A, WEIR L, et al.Prevention of smooth muscle cell outgrowth from human atherosclerotic plaque by a recombinant cytotoxin specific for the epidermal growth factor receptor[J].The Journal of Clinical Investigation, 1993, 91(2):724-729
[18]ROZTOCIL E, NICHOLL S M, GALARIA I I, et al.Plasmin-induced smooth muscle cell proliferation requires epidermal growth factor activation through an extracellular pathway[J].Surgery, 2005, 138(2):180-186
[19]RUDIC R D, BRINSTER D, CHENG Y, et al.COX-2-derived prostacyclin modulates vascular remodeling[J].Circulation Research, 2005, 96(12):1240-1247
[20]WANG K, TARAKJI K, ZHOU Z, et al.Celecoxib,a selective cyclooxygenase-2 inhibitor,decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model[J].Journal of Cardiovascular Pharmacology, 2005, 45(1):61-67
[21]YANG H M, KIM H S, PARK K W, et al.Celecoxib,a cyclooxygenase-2 inhibitor,reduces neointimal hyperplasia through inhibition of Akt signaling[J].Circulation, 2004, 110(3):301-308
[22]RYU J yeon, JANG E H, LEE J, et al.Prevention of neointimal hyperplasia after coronary artery bypass graft via local delivery of sirolimus and rosuvastatin: network pharmacology and in vivo validation[J].Journal of Translational Medicine, 2024, 22(1):166-183
[23]SONG H T, CUI Y, ZHANG L L, et al.Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells[J]. Microvascular Research, 2020, 132: 104060. DOI:10.1016/j.mvr.2020.104060.[J].Microvascular Research, 2020, 132(132):104060-
[24]VAN DE STOLPE A, VAN DER SAAG P T.Intercellular adhesion molecule-1[J].Journal of Molecular Medicine (Berlin, Germany), 1996, 74(1):13-33
[25]YASUKAWA H, IMAIZUMI T, MATSUOKA H, et al.Inhibition of intimal hyperplasia after balloon injury by antibodies to intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1[J].Circulation, 1997, 95(6):1515-1522
[26]ZHANG K, CAO J, DONG R, et al.Early growth response protein 1 promotes restenosis by upregulating intercellular adhesion molecule-1 in vein graft[J]. Oxidative Medicine and Cellular Longevity, 2013, 2013: 432409. DOI:10.1155/2013/432409.
[27]VIJAKUMARAN U, YAZID M D, HJ IDRUS R B, et al.Molecular Action of Hydroxytyrosol in Attenuation of Intimal Hyperplasia: A Scoping Review[J]. Frontiers in Pharmacology, 2021, 12: 663266. DOI:10.3389/fphar.2021.663266.
[28]ZHANG J R, LU Q B, FENG W B, et al.Nesfatin-1 promotes VSMC migration and neointimal hyperplasia by upregulating matrix metalloproteinases and downregulating PPARγ[J]. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2018, 102: 711-717. DOI:10.1016/j.biopha.2018.03.120.
[29]SUN H J, ZHAO M X, REN X S, et al.Salusin-β Promotes Vascular Smooth Muscle Cell Migration and Intimal Hyperplasia After Vascular Injury via ROSNFκBMMP-9 Pathway[J].Antioxidants & Redox Signaling, 2016, 24(18):1045-1057
[30]MISRA S, FU A A, RAJAN D K, et al.Expression of hypoxia inducible factor-1 alpha,macrophage migration inhibition factor,matrix metalloproteinase-2 and -9,and their inhibitors in hemodialysis grafts and arteriovenous fistulas[J].Journal of vascular and interventional radiology: JVIR, 2008, 19(2 Pt 1):252-259
[31]MISRA S, FU A A, PUGGIONI A, et al.Increased shear stress with upregulation of VEGF-A and its receptors and MMP-2,MMP-9,and TIMP-1 in venous stenosis of hemodialysis grafts[J].American Journal of Physiology. Heart and Circulatory Physiology, 2008, 294(5):H2219-2230
[32]RYU J Y, JANG E H, LEE J, et al.Prevention of neointimal hyperplasia after coronary artery bypass graft via local delivery of sirolimus and rosuvastatin: network pharmacology and in vivo validation[J].Journal of Translational Medicine, 2024, 22(1):166-
[33]TANG F, LIU M, ZENG O, et al.Gefitinib-coated balloon inhibits the excessive hyperplasia of intima after vascular injuries through PI3KAKT pathway[J].Technology and Health Care: Official Journal of the European Society for Engineering and Medicine, 2019, 27(S1):331-343
[34]SHIH Y C, CHEN P Y, KO T M, et al.MMP-9 Deletion Attenuates Arteriovenous Fistula Neointima through Reduced Perioperative Vascular Inflammation[J].International Journal of Molecular Sciences, 2021, 22(11):5448-
[35]FANG H, YANG S, LUO Y, et al.Notoginsenoside R1 inhibits vascular smooth muscle cell proliferation,migration and neointimal hyperplasia through PI3KAkt signaling[J].Scientific Reports, 2018, 8(1):7595-
[36]RATTI S, MAURO R, ROCCHI C, et al.Roles of PI3KAKTmTOR Axis in Arteriovenous Fistula[J].Biomolecules, 2022, 12(3):350-
[37]SHIH Y C, CHEN P Y, KO T M, et al.MMP-9 Deletion Attenuates Arteriovenous Fistula Neointima through Reduced Perioperative Vascular Inflammation[J].International Journal of Molecular Sciences, 2021, 22(11):5448-
[38]PROTACK C D, FOSTER T R, HASHIMOTO T, et al.Eph-B4 regulates adaptive venous remodeling to improve arteriovenous fistula patency[J].Scientific Reports, 2017, 7(1):15386-
[39]GUO X, FEREYDOONI A, ISAJI T, et al.Inhibition of the Akt1-mTORC1 Axis Alters Venous Remodeling to Improve Arteriovenous Fistula Patency[J].Scientific Reports, 2019, 9(1):11046-
[40]WAN J, LATA C, SANTILLI A, et al.Supplemental oxygen reverses hypoxia-induced smooth muscle cell proliferation by modulating HIF-alpha and VEGF levels in a rabbit arteriovenous fistula model[J].Annals of Vascular Surgery, 2014, 28(3):725-736
[41]WANG F, FAN X, KONG J, et al.Inhibition of mitochondrial fission alters neo-intimal hyperplasia via PI3KAkt signaling in arteriovenous fistulas[J].Vascular, 2023, 31(3):533-543
